21st Annual World Congress on Anti-Aging, Regenerative and Aesthetic Medicine

Register Online
Las Vegas, NV, USA – December 12, 2013: Pellet Therapy Workshop
$595
Las Vegas, NV, USA – December 12, 2013: Testosterone Deficiency and Therapy in Men
$595
Las Vegas, NV, USA – December 12, 2013: Practice Management Certification - Part 1
$895
Las Vegas, NV, USA – December 12, 2013: Personalized Lifestyle Medicine
$595
Las Vegas, NV, USA – December 12, 2013: Advances in Body Contouring
$595
Las Vegas, NV, USA – December 15, 2013: Menopause/Andropause: BHRT
$595
Las Vegas, NV, USA – December 13-15, 2013: Conference Registration - MEMBER
$695
Las Vegas, NV, USA – December 13-15, 2013: Conference Registration - NON-MEMBER
$895
Las Vegas, NV, USA – December 13-15, 2013: Conf. Registration - Aux Staff - NON-MEMBER
$495
Las Vegas, NV, USA – December 13-15, 2013: Sexual Health Module D
$1,499
Las Vegas, NV, USA – December 13-15, 2013: FAARM Module I
$2,750
Las Vegas, NV, USA – December 13-15, 2013: FAARM Module V
$2,750
Las Vegas, NV, USA – December 13-15, 2013: FAARM Module XVI(D)
$2,250
Las Vegas, NV, USA – December 13-15, 2013: FAARM Module XXII
$2,250
Las Vegas, NV, USA – December 13-15, 2013: FAARM Module XXIII(C)
$1,500
Las Vegas, NV, USA – December 13-15, 2013: ICT Module VIII
$2,500
 
 

Anti-Aging Conference
in Orlando, FL

May 15-17, 2014

Don't Wait! REGISTER NOW!

 

Left Until This Event!

online modules button
Fellowship Modules Online
online modules button

2013 Las Vegas Module ICT VIII

Course Description Top

This module conveys the role of nutrients in cancer therapy, including those that can increase or decrease the effectiveness of radiation and chemotherapy, inhibit cancer-dependent enzymes, cause apoptosis of cancer cells, inhibit tumor invasion or enhance the immune system. Also discussed are nutrient and herb interactions with conventional cancer therapies.

Objectives Top

Upon completion of this module, the participants will:

  • Learn advanced integrative approaches to cancer therapies
  • Explore clinical approaches to structural imbalances
  • Learn what determines test result accuracy, sources of error and what is involved in the management of quality assurance systems in a clinical laboratory
  • Understand how reference ranges are established and displayed
  • Understand organic acid metabolism and how this relates to evaluating nutrient insufficiency and toxic imbalances
  • Learn how to evaluate a patient's level of oxidative stress
  • Understand how urinary porphyrin analysis can evaluate functional effects of environmental toxins
  • Learn how to evaluate a patient's level of vitamins, minerals, and toxic metals
  • Understand the use and advantages of DNA identification of stool microbes
  • Learn the use of genomic analysis in the management of patient health risks
  • Learn how to evaluate patient levels of phthalates and other bioactive plasticizers and how this can affect steroid hormone interactions and potential health risks
  • Learn how analysis of stool microbes, chemistry, immunology and enzymology can be used to evaluate and treat intestinal disorders
  • Know treatments for psychiatric illnesses from an anti-aging and Metabolic approach
  • Learn nutritional support programs for the competitive athlete
  • Learn the role that nutrients play in the treatment of psychiatric illness
  • Write prescriptions for exercise plans for healthy patients and those with special needs
  • Learn new treatment modalities in the area of sports medicine from a an Anti-Aging and Metabolic approach
  • Learn how to wean a patient successfully off of prescription medications such as hypnotics and antidepressants
  • Review the biochemical basis of psychiatric diseases
  • Discuss the neurobiology and chemistry of the sleep wake cycle in the context of circadian rhythms and identify treatable disorders that can interrupt restorative sleep
  • Explain the role of the orexin secreting neurons in sleep disorders, including narcolepsy/cataplexy
  • Map a treatment or interventional plan to optimize restorative sleep
  • Introduce the principles of functional medicine, focusing on biochemical individuality
  • Explore the relationship between genes and environment as risk factors for disease, as well as opportunities to optimize health and well-being
  • Discuss the importance of laboratory testing that emphasizes optimal wellness and looks at factors that change before the outward manifestation of disease. Case histories will be discussed
  • Emphasize the fundamental functional imbalances that every clinician should consider when seeing a patient: environmental inputs, immune and inflammatory imbalance, energy production/oxidative stress, gastro-intestinal imbalance, detoxification and biotransformation, hormonal and neurotransmitter imbalance, structural imbalance and emotional imbalance
  • Apply the new-found understanding of the gene-environment interaction in clinical practice
  • Understand the reasons for the failure of traditional chemotherapy
  • Learn how to use targeted chemotherapy
  • Learn new protocols for advanced stage cancers
  • Have a basic understanding of how clinical lab tests are run
  • Learn how to detect and treat food allergies and how this can affect health
  • Understand how to evaluate a patient’s level of vitamins, minerals and toxic metals
  • Understand organic acid metabolism and how this relates to evaluating nutrient insufficiency and toxic imbalances
  • Learn how analysis of stool microbes, chemistry, immunology and enzymology can be used to evaluate and treat intestinal disorders
  • Understand the use and advantages of DNA identification of stool microbes
  • Learn how anaerobic bacterial imbalances in the gut can affect health and treatments
  • Learn the use of genomic analysis in the management of patient health risks
  • Learn how to evaluate patient levels of phthalates and other bioactive plasticizers, how this can affect steroid hormone interactions and potential health risks
  • Recommend appropriate mineral and vitamin repletion based on exercise needs
  • Recommend the correct protein to carbohydrate ratios and specific sources to optimize nutrient timing depending on age
  • Recommend amino acids that are evidenced based to improve recovery from a strenuous exercise program
  • Recommend nutraceuticals and herbal compounds that will reduce lactate loading and reperfusion injury
  • Recommend the appropriate nutrients to support inflammation and post surgery recovery
  • Investigate the role that diet has in cancer prevention
  • Review existing and new research on metabolic therapies for the treatment of cancer
  • Identify scientific rationale for using antioxidant/micronutrient/ phytochemical combinations with standard conventional cancer therapies
  • Review literature concerning nutriceuticals and if they can be used as complementing cancer therapies
  • Address alternative treatment of specific cancer types
  • Learn therapies that may prevent or treat the side effects of radiation or chemotherapy
  • Develop a step-by-step guide to the safe and gradual withdrawal from tranquilizers, anti-depressants, and sleeping aids
  • Identify the symptoms of anti-depressant and hypnotic medication withdrawal
  • Learn nutritional support for benzodiazepine withdrawal
  • Learn the effects that anti-depressants have on the brain
  • Learn nutritional support for discontinuation of SSRIs, tricyclic and MAO inhibitor anti-depressants
  • Learn nutritional support for hypnotic withdrawal
  • Know the anti-depressant-induced mental, behavioral, and cerebral abnormalities that can occur with their use
  • Learn metabolic treatments for depression, anxiety, OCD, schizophrenia, and manic depression
  • Recognize the biochemical imbalances that result in a mental illness
  • Understand the decline in endocrine function that occurs in all organs with age
  • Know the behavioral effects of endocrine disorders and their application to geriatric psychiatry
  • Lean laboratory abnormalities that occur with hyperparathyroidism
  • Learn the mechanisms of action of PTH
  • Recognize the drug effects that occur in bone strength
  • Understand how the mode of delivery of PTH determines the skeletal response to PTH
  • Review the literature on the effect PTH treatment has on the risk of vertebral fractures in postmenopausal women with osteoporosis

Speakers Top

Mark Rosenberg, MD

Dr. Rosenberg has been involved with drug research since 1991. Having studied the mechanisms of cancer treatment failure, the following concept has become blatantly apparent to Dr. Rosenberg. There are many substances that are toxic to cancer cells in vitro (outside of the body, in a culture medium), including chemotherapy and intravenous antioxidant therapy. These therapies, however, are more often then not, ineffective in vivo (inside the body). The primary reason for the ineffectiveness is that tumor blood flow is poor, resulting in a tumor that actually receives very little of the cytotoxic therapy that is being administered. In addition, poor tumor blood flow is associated with higher grade tumors and greater incidence of metastasis.

Dr. Rosenberg has since concentrated his efforts on improving blood flow to the cancer, while administering cytotoxic intravenous antioxidant therapy. In addition to using vasodilating therapy such as carbogen and isosorbide dinitrate, Dr. Rosenberg has just been granted approval status for an IND (investigational new drug) using Angiotensin II. Angiotensin II is frequently used in Japan in conjunction with chemotherapy to improve tumor blood flow.

Dr. Rosenberg recently appeared on Fox News in 2006, for inducing remission on a patient with metastatic lung cancer (to liver and spine) that was refractory to chemotherapy.


Akbar Khan

Dr. Khan is a graduate of the University of Toronto, Faculty of Medicine (1992). He completed his certification in Family Medicine in 1994 (also at University of Toronto). After completion of his family medicine training, he immediately joined a palliative home care team at his local hospital. This
is how his focus on cancer patients began.  In 1999, Dr. Khan co-founded P.A.L.I.N., a registered charitable corporation which addressed the growing needs of cancer patients requiring at-home symptom control and enhanced quality of life.  In 2006, Dr. Khan co-founded Medicor Cancer Centres, the first integrated private cancer clinic of its kind in Canada. Since 2007, Dr. Khan gained international recognition and has been treating
patients from all over the world. He is privileged to be the first doctor in the world to prescribe offlabel dichloroacetate (DCA) to treat cancer with positive results. As a result, he now has the most DCA experience of any physician in the world with over 1400 cancer patients treated as of October 2013. He is also the first in the world to demonstrate the curative potential of DCA when used as an adjuvant to chemotherapy or radiotherapy (one case published, second publication pending).
Dr. Khan is regularly publishing ground-breaking cancer papers in peer-reviewed medical journals.




Dwight McKee

Dr. McKee graduated from Williams College with honors in chemistry in 1970. He then entered a combined M.D.-Ph.D. program at Case-Western Reserve University in Cleveland, Ohio, where he completed the first 2 years of medical school, as well as full graduate studies in pharmacology, and 1 year of research. After changing his interest from laboratory research to clinical medicine, he completed his last 2 years of medical school at the University of Kentucky, in Lexington Ky, where he received his M.D. degree in 1975. After a rotating internship at the Washington Hospital Center in Wash. D.C., he became associate medical director of Integral Health Services in Putnam, CT.—the first integrative medicine clinic on the east coast. Over the next 12 years he studied and practiced nutritional and mind/body medicine, along with a full range of complementary medicine disciplines. Thru working with cancer patients in his practice, he became increasingly interested in cancer medicine, which led him in 1988 to return to hospital based post-graduate training in internal medicine at Los Angeles County Hospital, Santa Clara Valley medical center, and Stanford University. After becoming Board Certified in Internal Medicine, he completed a 3 years fellowship in Hematology and Oncology at the Scripps Clinic, in La Jolla, CA, and subsequently became Board Certified in both disciplines. He was also a Visiting Scientist at The Scripps Research Institute Immunology division for 2 years, where he pursued advanced studies in immunology, and performed laboratory research in tumor immunology. Since completing training in medical oncology, hematology, and immunology, Dr. McKee has been involved in the development of integrative cancer care, creating a synthesis between conventional cancer medicine and alternative/complementary medicine. In 2003 he became Board Certified in nutrition through the American College of Nutrition, and in 2007 he became Board Certified in Integrative and Holistic medicine through the American Board of Holistic Medicine In 2008 he co-authored a text book on Herb, Nutrient, and Drug Interactions, which is used as a text in most of the naturopathic colleges, at many medical schools, as well as by many integrative medical practitioners.



Eric Marsden

Dr. Marsden obtained his undergraduate degree in Human Biology at the University of Toronto and completed his graduate studies in Naturopathic Medicine at the Canadian College of Naturopathic Medicine (CCNM) in Toronto. He is the clinic director at MCNE and postgraduate residency director of the only Naturopathic Oncology residency in Canada. Dr. Marsden has received several awards for clinical excellence including the OAND’s Chair’s award for outstanding contribution to the naturopathic profession.


Paul Anderson

Dr. Anderson is medical director of Anderson Medical Specialty Associates, a clinic focusing on the care of patients with cancer and chronic diseases.  Former positions include professor of Pharmacology and Clinical Medicine at Bastyr University and Chief of IV Services for Bastyr Oncology Research Center.  He is a graduate of NCNM and began instructing courses in medical programs in the early 1990’s.  He continues to hold board review classes and CME courses for most of the US and Canadian ND programs including BU, NCNM, Boucher Institute, UB, SCNM and CCNM. He also is a founding board member of the Academy of Parenteral Therapies specialty group and an instructor and author for the IIVNTP IV Therapy training group.


Schedule Top

Friday, December 13, 2013:
7:30am
Holistic vs. Biomedical Models of Palliative Care; Management of Cancer Pain with Integrated Botanicals and Pharmaceuticals; Role of Cannabis in Palliative Care
Dwight McKee, MD
9:30am
BREAK
10:00am
Novel Integrated Approaches for Cancer Patients with Advanced Disease
Eric Marsden, ND
12:00pm
LUNCH (On Your Own)
1:30pm
Overview of Integrative Palliative Care, Part 1
Akbar Khan, MD
2:30pm
Overview of Integrative Palliative Care, Part 2 Akbar Khan, MD
3:30pm
BREAK
4:00pm Metabolic Therapy with Dichloroacetate Akbar Khan, MD
5:00pm
Novel Integrated Approaches for Cancer Patients with Advanced Disease (Continued) Eric Marsden, ND
6:00pm
CLOSE OF SESSION

Satuday, December 14, 2013:
7:30am
Novel Integrated Approaches for Cancer Patients with Advanced Disease (Continued) Eric Marsden, ND
8:30am Anti-Angiogenic Therapy with Copper Chelation Akbar Khan, MD
9:30am
BREAK
10:00am
Immunotherapy with Low Dose Naltrexone
Akbar Khan, MD
11:00am
Novel Integrated Approaches for Cancer Patients with Advanced Disease (Continued) Eric Marsden, ND
12:00pm
LUNCH (On Your Own)
1:30pm
Differentiating Agents
Akbar Khan, MD
2:30pm
Novel Integrated Approaches for Cancer Patients with Advanced Disease (Continued)
Eric Marsden, ND
3:30pm
BREAK
4:00pm
Novel Integrated Approaches for Cancer Patients with Advanced Disease (Continued)
Eric Marsden, ND
4:30pm Euthenasia and Assisted Suicide Akbar Khan, MD
5:30pm Advanced Pain Assessment and Management Akbar Khan, MD
6:00pm
CLOSE OF SESSION

Sunday, December 15, 2013:
7:00am
Advanced Pain Assessment and Management (Continued)
Akbar Khan, MD
7:30am Non Parenteral Palliative Care  Paul Anderson, ND
8:30am Parenteral Therapies in Palliative Care and Quality of Life Paul Anderson, ND
9:00am
BREAK
9:30am
Parenteral Therapies in Palliative Care and Quality of Life (Continued)
Paul Anderson, ND
11:30am
LUNCH (On Your Own)
1:00pm
Parenteral Uses of Ascorbate: Research Outcomes and Implications for Cancer Care
Paul Anderson, ND
3:00pm
BREAK
3:30pm
Novel Parenteral Compounds in Oncology
Paul Anderson, ND
4:30pm TBD Mark Rosenberg, MD
5:30pm
CLOSE OF SESSION